Arterial blood gases and some blood parameters in Tetralogy of Fallot patients

Edrees Mohammad Ameen

doi:10.21271/ZJPAS.33.3.12

Authors

Edrees Mohammad Ameen Department of Biology, College of Science, Salahaddin University-Erbil, Kurdistan Region, Iraq

DOI:

https://doi.org/10.21271/ZJPAS.33.3.12

Keywords:

Tetralogy of Fallot; PaO2; PaCO2; PCV; Surgical correction; Base Excess.

Abstract

The present study was done to assess the effect of the tetralogy of Fallot (TOF) on some arterial blood measurements including pH, the partial pressure of carbon dioxide (PaCO2), the partial pressure of oxygen (PaO2), Base excess (BE), Red blood cells (RBC), Packed cell volume (PCV), and Hemoglobin (Hb) concentration in the Erbil City of Iraq. For this purpose 80 (40 males and 40 females) patients with (TOF) and aged between 3-33 years were used in this study. This retrospective cohort study was conducted from March /2018 to October 2020 and carried out in the Surgeries Hospital Specialist - Cardiac Center in Erbil city. The studied parameters were estimated before and two to three weeks after postoperative correction of TOF. A dependent t-test was used for data analysis. The results showed that males and females with (TOF) after surgical correction have significantly p≤ 0.001 lower PaCO2, RBC, PCV, and Hb concentration, while the concentration of PaO2 and the value of BE were significantly p≤ 0.001 higher after surgical correction in comparison with the value before surgery. Moreover, males showed a significantly higher concentration of RBC, PCV, and hemoglobin than females after surgical correction. Conclusions: Surgery repair of (TOF) restore the arterial blood measurements PaCO2, PaO2, BE, RBC, PCV, and Hb concentration to the normal value in males and females.

References

ABDULLA, R. 2011. Heart Diseases in Children: A Pediatrician's Guide, Springer Science & Business Media.

AGARWALLA, B. 2017. Tetralogy of Fallot. Journal of Cardiology, 1, 1-5.

BAILLIARD, F. & ANDERSON, R. H. 2009. Tetralogy of fallot. Orphanet Journal of Rare Diseases, 4, 1-10.

BHARDWAJ, V., KAPOOR, P. M., IRPACHI, K., LADHA, S. & CHOWDHURY, U. K. 2017. Basic arterial blood gas biomarkers as a predictor of mortality in tetralogy of Fallot patients. Annals of cardiac anaesthesia, 20, 67-71.

DOROBANTU, D. M., SHARABIANI, M. T., TALIOTIS, D., PARRY, A. J., TULLOH, R. M., BENTHAM, J. R., CAPUTO, M., VAN DOORN, C. & STOICA, S. C. 2020. Age over 35 years is associated with increased mortality after pulmonary valve replacement in repaired tetralogy of Fallot: results from the UK National Congenital Heart Disease Audit database. European Journal of Cardio-Thoracic Surgery, 58, 825-831.

FISCHBACH, F. T. & DUNNING, M. B. 2009. A manual of laboratory and diagnostic tests, Lippincott Williams & Wilkins.

GUNDUZ, E., GORGEL, A., DURSUN, R., DURGUN, H. M., CIL, H., ICER, M. & ZENGIN, Y. 2014. A Case of Uncorrected Tetralogy of Fallot Undiagnosed Until Adulthood and Presenting With Polycythemia. Cardiology research, 5, 198-200.

HAY, W. W., LEVIN, M. J., DETERDING, R. R., ABZUG, M. J. & SONDHEIMER, J. M. 2009. Current diagnosis & treatment: Pediatrics, McGraw-Hill Medical.

HICKEY, E. J., VELDTMAN, G., BRADLEY, T. J., GENGSAKUL, A., MANLHIOT, C., WILLIAMS, W. G., WEBB, G. D. & MCCRINDLE, B. W. 2009. Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades. European Journal of cardio-thoracic Surgery, 35, 156-164.

JOSOS, C. & JUDAS, E. 2020. Tetralogy of Fallot & DiGeorge syndrome. American Heart Association.

LONG, W. A. & DUFFY, C. E. 1990. Fetal and neonatal cardiology. WB Saunders, Philadelphia.

MACKIE, A. S., IONESCU-ITTU, R., THERRIEN, J., PILOTE, L., ABRAHAMOWICZ, M. & MARELLI, A. J. 2009. Children and adults with congenital heart disease lost to follow-up: who and when? Circulation, 120, 302-309.

MURPHY, J. G., GERSH, B. J., MAIR, D. D., FUSTER, V., MCGOON, M. D., ILSTRUP, D. M., MCGOON, D. C., KIRKLIN, J. W. & DANIELSON, G. K. 1993. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. New England Journal of Medicine, 329, 593-599.

OUELLET, J.-F., ROBERTS, D. J., TIRUTA, C., KIRKPATRICK, A. W., MERCADO, M., TROTTIER, V., DIXON, E., FELICIANO, D. V. & BALL, C. G. 2012. Admission base deficit and lactate levels in Canadian patients with blunt trauma: are they useful markers of mortality? Journal of Trauma and Acute Care Surgery, 72, 1532-1535.

PALADINO, L., SINERT, R., WALLACE, D., ANDERSON, T., YADAV, K. & ZEHTABCHI, S. 2008. The utility of base deficit and arterial lactate in differentiating major from minor injury in trauma patients with normal vital signs. Resuscitation, 77, 363-368.

REPLOGLE, R. L., MEISELMAN, H. J. & MERRILL, E. W. 1967. Clinical implications of blood rheology studies. Circulation, 36, 148-160.

SHINEBOURNE, E. A., BABU-NARAYAN, S. V. & CARVALHO, J. S. 2006. Tetralogy of Fallot: from fetus to adult. Heart, 92, 1353-1359.

SIRHAN, S., FAIRBANKS, V. F. & TEFFERI, A. 2005. Red cell mass and plasma volume measurements in polycythemia: evaluation of performance and practical utility. Cancer, 104, 213-215.

SOMMER, R. J., HIJAZI, Z. M. & RHODES JR, J. F. 2008. Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions. Circulation, 117, 1090-1099.

TERRITO, M. C. & ROSOVE, M. H. 1991. Cyanotic congenital heart disease: hematologic management. Journal of the American College of Cardiology, 18, 320-322.

THORNE, S. 1998. Management of polycythaemia in adults with cyanotic congenital heart disease. BMJ Publishing Group Ltd.

VAN DER VEN, J. P., VAN DEN BOSCH, E., BOGERS, A. J. & HELBING, W. A. 2019. Current outcomes and treatment of tetralogy of Fallot. F1000Research, 8, 1-15.

WARRELL, D., COX, T., FIRTH, J. & BENZ, E. 2003. Cyanotic Heart Disease: A Multisystem Disorder. Oxford Textbook of Medicine, 4th edition. London: Oxford University Press.

WILSON, R., ROSS, O. & GRIKSAITIS, M. J. 2019. Tetralogy of Fallot. BJA Education, 19, 362-369.